Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Bone Marrow Neoplasms × Hydroxyurea × Clear all

Status

Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 6 Glioblastoma 5 Squamous Cell Carcinoma of Head and Neck 4 Leukemia, Myeloid, Acute 4 Gliosarcoma 4 Neoplasms 3 Meningioma 3 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Head and Neck Neoplasms 3 Glioma 3 Polycythemia Vera 2 Myelodysplastic Syndromes 2 Leukemia, Myeloid, Chronic-Phase 2 Leukemia 2 Laryngeal Neoplasms 2 Esophageal Neoplasms 2 Central Nervous System Neoplasms 2 Tongue Neoplasms 1 Thrombosis 1 Thrombocytosis 1 Stomach Neoplasms 1 Salivary Gland Neoplasms 1 Primary Myelofibrosis 1 Polycythemia 1 Pharyngeal Neoplasms 1 Paranasal Sinus Neoplasms 1 Papillomavirus Infections 1 Pancreatic Neoplasms 1 Oropharyngeal Neoplasms 1 Oligodendroglioma 1

Interventions

ruxolitinib 1 Stem Cell Transplantation 1 Low-Level Light Therapy 1 Hydroxyurea 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04217356 2026-01-26

ALLO-BAT

University Health Network, Toronto

Active not recruiting

Bone Marrow Neoplasms, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡